Major Breakthrough in Myopia Control
World Congress on Myopia Control
Session One, August 2023 ~ August 2024
August 03, 2024 | Major Breakthrough in Myopia Control | 08 AM Eastern Daylight Time (US and Canada)
03 de Agosto de 2024 às 9h (Hora de Brasília)
9h05
Low Level Red Light in Myopia Control
Mingguang He | China
9h40
Environment Control - Clouclip
Weizhong Lan | China
10h20
Violet Light Therapy for Myopia
Kazuo Tsubota & Richard Hida | Japan/Brazil
Alternative Pharmacological Treatment in the Progression of Myopia
Carlos Kotlik | Argentina
President:
Dr. Tania Schaefer
Organizing committee:
Dr. Fernando Abib
Dr. Paulo Ricardo de Oliveira
Coordination
Tania Schaefer, Regina Noma, Izabela Godinho
Scientific Direction
Celso Cunha
Participants:
Abel Szeps, Maria Angélica Rivas, Carlos Arce, Carlos Kotlik, Célia Nakanami, Celso Cunha, Fábio Ejzenbaum, Galton Vasconcelos, Leonardo Fernández Irigaray, Luiz Felipe Lynch, Marcelo Sobrinho, Marcos Vinicius de Souza, Patrícia Gus, Penny Asbel, Rafael Iribarren, Richard Hida.
Speakers

Mingguang He
China
Professor of Ophthalmology and principal investigator of Ophthalmic Epidemiology and Clinical Intervention Research. Major goals: establish a worldwide shared medical, environmental and genetic database of natural population and patients with eye diseases; clarify clinical characteristics, determine classification criteria and molecular typing, creating risk and prognosis prediction models; carry out evidence-based evaluation and randomized controlled studies of new diagnostic and therapeutic technologies, and gradually establish a standard and accurate medical system for ophthalmic diagnosis and treatment.

Weizhong Lan
China
Dr Lan is a full professor in Central South University, China and the vice director of Aier Institute of Optometry and Vision Science, Aier EYE Hospital Group. He finished his clinical training as an Ophthalmologist in Zhongshan Ophthalmic Center (China) and achieved his M.D / Ph.D in Neuroscience from the University of Tuebingen (Germany). His main interest is to understand the pathogenesis of myopia and to develop new approaches to correct and control myopia. He has led more than 10 clinical trials investigating the efficacy and safety of anti-myopia interventions. He is also the co-inventor of the first wearable device to collect myopia-related environmental factors in the world, called Clouclip®. Recently he and his team won the bid of hosting the International Myopia Conference (IMC) 2023 in China.

Kazuo Tsubota
Japan
MD, PhD, MBA is the CEO of Tsubota Laboratory, Inc., established in 2015. He is also a professor emeritus of the Dept. of Ophthalmology at Keio University School of Medicine in Tokyo, Japan, his alma mater. Dr. Tsubota completed clinical and research fellowships at Harvard Medical School in 1987 and is an internationally recognized dry eye specialist.

Richard Hida
Brazil
Director of the Ocular Surface Study Group at the Department of Ophthalmology at the University of São Paulo (USP);
Surgical Optics Sector (Cataract and Refractive) – Department of Ophthalmology – Federal University of São Paulo (UNIFESP);
Cataract Sector – Department of Ophthalmology – University of São Paulo (USP); and President of BLOSS – the Brazilian Society of Laser and Ophthalmic Surgery

Carlos Kotlik
Argentiina
Main physician at the Service of Ophthalmology at Notti children’s Hospital in Mendoza Argentina; Associate Professor in Ophthalmology at the School of Medicine, National University of Cuyo, in Mendoza; completed training programs in France, the USA, and India; interested in Optometry, ophthalmic pediatrics and refractive surgery with several papers published in different journals; member of the American Academy of Ophthalmology since 1993 and other scientific organizations; editor of the MO journal of the Argentine Council of Ophthalmology ; member of the Argentine Scientific Group of Myopia Control.